Researchers from the Cleveland Clinic Genome Center have successfully applied advanced artificial intelligence (AI) genetics ...

“We believe that therapeutic modalities like gene therapy can change the treatment landscape for people living with the debilitating effects of Parkinson’s disease and look forward to seeing ...

Armed with data from a small phase 1/2 bridging study, MeiraGTx is preparing to take its gene therapy for Parkinson's disease into a pivotal trial. Shares in the Anglo-US biotech rose sharply ...

In trials at University College London Hospitals (UCLH), an ASO is being used to target the mutated gene that results in the ...

Base editing utilizes enzymes to modify single amino acids at the most foundational unit of DNA, called a base.

In two new papers, researchers from The Jackson Laboratory (JAX) report the successful use of two approaches—gene therapy and ...

AskBio begins patient randomizing in phase II gene therapy trial for Parkinson’s disease: Berlin, Germany Wednesday, January 15, 2025, 14:00 Hrs [IST] AskBio Inc. (AskBio), a ge ...

Currently there are seven drug candidates for Parkinson’s disease in Phase III trials ... in our efforts to advance our cell and gene therapy pipeline and deliver on our ambition to be an ...

14, 2025 — There may be a link between hearing impairment and an increased risk of developing Parkinson's according ... for a given disease against five databases that provide gene-disease ...

Additional details on the meeting can be found at the WORLD Symposium website. About Spur Therapeutics Spur Therapeutics is a clinical-stage biotechnology company focused on developing life-changing ...